Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy

CD47 and its receptor signal regulatory protein α (SIRPα) act as a dominant antiphagocytic, “don’t eat me” signal. Recent studies reveal CD24 as a novel target for cancer immunotherapy by macrophages in ovarian cancer and breast cancer. However, whether simultaneous blockade of CD47 and CD24 by a bi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yun Yang, He Wu, Yan Yang, Yan Kang, Runjia He, Bei Zhou, Huaizu Guo, Jing Zhang, Jianqin Li, Chunpo Ge, Tianyun Wang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-12-01
סדרה:	Molecular Therapy: Oncolytics
נושאים:	CD47 CD24 macrophages bispecific antibody antitumor immunity
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2372770523000967
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!